Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Autism Case Training (Continuing Education)


Case Study A:

Early Intervention and Education

Appropriate, early, intensive educational therapies greatly improve long-term outcomes for children with autism spectrum disorder (ASD). Effective primary care management of ASD includes supporting families by providing referrals for appropriate therapies and community resources.

Case Study B:

Treatments for Autism Spectrum Disorder

Children with ASD often present with challenging or maladaptive behaviors that are commonly seen in addition to the core deficits. Pediatricians are often called upon to help evaluate children for underlying medical concerns and to facilitate obtaining appropriate treatment.

Case Study C:

Autism Spectrum Disorder-Specific Anticipatory Guidance

Children with ASD present with issues and challenges similar to those of typically developing children, but special consideration may be needed when evaluating these issues and providing anticipatory guidance to families.

Continuing Education

This module has been approved for the following:

  • CME: 2.25
  • CNE: 2.2
  • CEU: 0.2

Following completion of all case studies in a module, please go to to evaluate the course and receive a certificate of completion. You can also print an ongoing transcript of all your TCEOnline CE activities to secure continuing education hours. You must complete all case studies in this module to receive continuing education hours; you can take them at once or at different times.

Detailed instructions on how to obtain CE hours is provided in the “Course Information” link in the top right corner in each case.

CME and Maintenance of Certification Approved

Physicians who complete all three modules and provide an accurate American Board of Pediatrics (ABP) number will also be credited 20 points toward Maintenance of Certification Part 2 through ABP.

The American Board of Pediatrics portfolios will be updated to reflect credit by the 10th of the month following completion of all courses. Any modules completed after December 1 will be credited for the following year. ABP will notify you by email when points have been applied. Direct any questions about this process to

Accreditation Statements

  • Continuing Medical Education for Physicians (CME):
    The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

    The Centers for Disease Control and Prevention designates this enduring educational activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Continuing Nursing Education for Nurses (CNE):
    The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

    This activity provides 2.2 contact hours.

  • IACET Continuing Education Units (CEU):
    The Centers for Disease Control and Prevention is authorized by IACET to offer .2 CEU's for this program.


CDC, our planners, and our content experts wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Bridgemohan, Dr. Huffman, Dr. Farrell, and Dr. Tang’s modules on Early Intervention and Education and Treatments for Autism Spectrum Disorders. These modules discuss many of the medications used to help with maladaptive behaviors and psychiatric co-morbidities prevalent in children with ASD which are used off-label. A primary care provider may encounter a child with an ASD on one or more of these medications in the course of his or her practice. It is important to be aware of side-effect profiles, contraindications, and health monitoring in children on these medications. While side effects should be monitored by the prescriber, the primary care provider also needs to make sure these are monitored, be aware of the possible drug interactions with other medications prescribed, and know the side effects so they can be considered in the differential diagnosis of symptoms brought to the primary care office for treatment. This case educates users on medications others may be prescribing for their patients, so they can understand and best manage their patient’s overall health and well being. The primary care provider should be aware of which are FDA approved and which are not.

CDC does not accept commercial support.